tissues taken from animals that were killed within 4 weeks postchallenge. Tuberculin reactivity in vivo and in vitro and antimycobacterial resistance were also measured. BCG vaccination protected the guinea pigs and resulted in significantly enhanced proportions of T,u cells in the blood during the first 2 weeks and in the spleen during weeks 2 and 3 postchallenge. Levels of T-y cells declined in all tissues during the first 3 weeks of infection and were unaffected by prior vaccination with BCG. Increased proportions of T,u cells in the blood were accompanied by dramatic tuberculin skin reactions and purified protein derivative-induced lymphoproliferation in BCG-vaccinated guinea pigs during the first 2 weeks following virulent pulmonary challenge. Peak levels of T,u cells in the spleens of vaccinated animals at 2 weeks coincided with the first appearance of virulent mycobacteria in that organ. BCG vaccination appears to influence immunoregulatory events in pulmonary tuberculosis through effects on the distribution of IgM Fe receptor-bearing (T,u cell) T lymphocytes.
Although more than a century has elapsed since Robert Koch discovered the tubercle bacillus (9) , detailed knowledge of relevant immune responses, particularly mechanisms regulating acquired anti-tuberculosis resistance, are incompletely understood. Tuberculosis remains a major cause of morbidity and mortality in developing countries, while also resurging in certain areas of the United States because of its role as an opportunistic pathogen in patients with acquired immune deficiency syndrome. Global control of tuberculosis relies primarily on the only vaccine that is currently available, Mycobacterium bovis BCG. Unfortunately, BCG vaccination has failed to consistently induce protective immunity in human field trials (1, 25) . This finding suggests the need to define the cellular interactions that operate to regulate protection in patients with tuberculosis.
The spectrum of immune responses against tuberculous infection ranges from protective immunity to immunosuppression, with the thymus-dependent (T) cell being a central participant in both (1) . T-cell heterogeneity has been defined in most studies of tuberculous immunity by the presence of phenotypic surface markers for helper and inducer (CD4) or suppressor and cytotoxic (CD8) T cells, which are not always consonant with a particular T-cell function (5, 6). Therefore, functional surface receptors (e.g., Fc receptors and E rosette) may prove to be more relevant for delineating the T-cell subsets that are involved in successful antimycobacterial immunity.
In early work dissecting regulatory T-cell circuits, Moretta et al. (16) produce antibodies of the homologous isotype (11, 14) and in antibody-mediated cytotoxic reactions (17, 18) . While it is now apparent that the T,u and T-y cells may not comprise functionally distinct and unique subpopulations, there is evidence for the importance of FcR+ T lymphocytes in resistance to tuberculosis. In a recent clinical study, Kleinhenz and Ellner (8) have reported increased levels of Ty cells in the peripheral blood. of patients with active pulmonary tuberculosis in the absence of detectable alterations in the suppressor cell population characterized by the phenotypic marker Leu2a. They concluded that the T-y-cell population may mediate antigen-specific suppression, as evidenced by an enhanced proliferative response of cultured cells also to purified protein derivative (PPD) following depletion of the Ty-cell subset. In the same study, Ty cells also were capable of modulating antigen-specific suppression by monocytes, possibly functioning as contrasuppressor cells (8) .
In this study, using a well-established guinea pig model of experimental pulmonary tuberculosis (2, 21), we examined the effects of BCG vaccination on in vivo and in vitro parameters of cellular immunity. Using a double rosette assay, we assessed vaccine-related changes in T-y-and T,u-cell distribution in guinea pigs infected aerogenically with virulent Mycobacterium tuberculosis.
( Six weeks following BCG vaccination, all guinea pigs were infected via the respiratory route by using an aerosol chamber as described previously (27 Lymphocyte blastogenesis. Mitogen-and antigen-induced lymphoproliferation was assessed in vitro by an established procedure (2) . Total leukocyte count determination was performed on each blood sample by standard clinical procedures. Lymphocytes from peripheral blood were separated by density gradient centrifugation on lymphocyte separation medium (Organon Teknika Corp., Durham, N.C.). Lymphocytes at the interface were removed and washed three times in phosphate-buffered saline with 2% fetal bovine serum. The viability of blood lymphocytes was determined by trypan blue exclusion and counting in a hemacytometer. After the viability was determined, the cells were suspended in RPMI 1640 medium containing 10% fetal bovine serum, penicillin (100 U/ml), streptomycin (100 ,ug/ml), 2-mercaptoethanol (10 
RESULTS
Tuberculin responses and anti-mycobacterial resistance. BCG-vaccinated guinea pigs exhibited significantly (P < 0.01) stronger delayed-type hypersensitivity reactions to 100 tuberculin units of PPD than their nonvaccinated counterparts did during the first three intervals tested (Table 1) . Nonvaccinated animals displayed minimal responses during the first 2 weeks postchallenge; however, as the disease progressed, nonvaccinated guinea pigs were capable of mounting a significant dermal reaction to PPD which was not significantly different from that of BCG-vaccinated guinea pigs by week 4. The protective effect of BCG vaccination was apparent in the spleen viable counts (Table 1 ). Viable M. tuberculosis was first detected 2 weeks postchallenge. The first significant (P < 0.05) effect of vaccination was observed at 3 weeks as a 100-fold reduction in mycobacterial load which was maintained at the 4-week interval.
Lymphoproliferation in vitro. Results of lymphocyte proliferation to ConA and tuberculin PPD in vitro are given in Table 2 . PPD-induced blastogenesis was more pronounced in peripheral blood lymphocytes of BCG-vaccinated animals than it was in nonvaccinated animals in the first two sacrifice intervals. By 3 weeks fdllowing respiratory challenge with M. tuberculosis H437Rv, lymphocytes from nonvaccinated animals responded vigorously to PPD in vitro.
Lymphoproliferative responses of peripheral blood cells to ConA were strong and uniform across sacrifice intervals within each treatment group. During each interval lymphocytes from guinea pigs receiving the M. bovis BCG vaccine were significantly (P < 0.05) more responsive to the nonspecific mitogen than lymphocytes from animals that were not vaccinated, in spite of considerable variation from animal to animal.
The spontaneous proliferation of unstimulated (control) cells was low (400 to 900 cpm) and did not vary significantly with the treatment group from which the cells were obtained.
Impact of BCG vaccitiation on T,u cells. Figure 1 illustrates that vaccination resulted in significantly (P < 0.05) enhanced proportions of T lymphocytes bearing Fc receptors for IgM in the peripheral blood during the first 2 weeks following respiratory challenge with virulent M. tuberculosis. In other experiments, it was determined that base-line levels of Tp. cells in the blood of nonchallenged animals were 20 ± 2%. At (0) (Fig. 3) . In general, a significant downward trend in T-y-cell proportions was observed as the pulmonary infection progressed during the first 3 weeks following aerogenic infection. No major differences in Ty-cell numbers between vaccinated and nonvaccinated guinea pigs were demonstrated when absolute T-y values were calculated (data not shown).
Similar results were observed for this T-cell subset in the spleen (Fig. 4) ,ollowing aero-ated significant delayed-type hypersensitivity reactions to Base-line levels tuberculin (PPD), as well as increased proliferative re-,uinea pigs were sponses of peripheral blood lymphocytes to PPD in vitro. irtions observed
Previously, it has been demonstrated that BCG vaccination is efficacious against respiratory challenge with virulent M.
tuberculosis H37Rv in the guinea pig model (2, 12, 13, 21) . Successful vaccination minimizes hematogenous dissemination of tubercle bacilli to distal organs such as the spleen, may modulate resulting in significant reductions in the mycobacterial load
Ivith pulmonary in that organ (Table 1) . BCG also allows the animal to 1 dlstrbution of control the accumulation of mycobacteria in the primary lnly, BCG vacci-lung lesion during the first few weeks following low-dose
In a slgnificant pulmonary challenge (21) . However, since the principal the spleen and effect of vaccination appears to be the control of the dissem--spiratory chal-ination phase of infection (20) , spleen viable counts are a 'sues durng the better indication of the degree of resistance that is conferred. BCG also eliciCellular responses of vaccinated guinea pigs to tuberculin, both in vivo and in vitro, were predictable. Vaccinated animals responded vigorously to PPD skin tests at each interval that they were observed. As tuberculous disease progressed in nonvaccinated guinea pigs, the presence of a greater antigenic stimulus allowed for the development of a cell-mediated immune response, and these animals eventually mounted a cutaneous reaction to the intradermal delivery of mycobacterial antigen. In vitro tuberculin responses mimicked those demonstrated in vivo. Vaccinated guinea pigs exhibited more dramatic stimulation indices earlier in the disease process than nonvaccinated animals did, indicating an accelerated amplification of PPD-reactive T-cell clones in vaccine recipients. The development of tuberculinreactive lymphocytes in the peripheral blood of nonvaccinated guinea pigs required a longer interval following respiratory infection. However, the acquisition of PPDresponsive cells in the circulation of nonvaccinated animals 3 4 correlated with conversion to tuberculin reactivity in the skin. It is important that neither of these events was associ- (10) .
Prior BCG vaccination in guinea pigs with pulmonary tuberculosis significantly increased the proportion of T,u cells in both peripheral blood and spleens. The maximum percentage of T,u cells attained in the spleens of vaccinated animals correlated with the first detection of viable M. tuberculosis recovered from that organ 2 weeks postchallenge (Table 1) . Thus, the appearance of elevated levels of TR cells in the spleens precedes the demonstration of significant control of mycobacteria in that organ by 1 week ( Table 1) . We interpret this delay to reflect the time necessary for these putative regulatory TR cells to exert their beneficial effect on the anti-mycobacterial mechanisms, resulting in a reduced rate of mycobacteria accumulation which becomes detectable 7 days later. A temporal relationship was also observed between TR-cell levels in the peripheral blood of vaccinated guinea pigs and PPD reactivity. The early increase in T,u-cell percentages circulating in vaccinated animals during the first 2 weeks of infection corresponded to the initial presence of significant tuberculin responses both in vivo and in vitro. The later acquisition of PPD reactivity in nonvaccinated guinea pigs occurred concomitantly with increases in Tp-cell values at 4 weeks in both blood and spleens, similar to those observed in vaccinated animals. The fact that increased Tp-cell levels occurred at a time (4 weeks) when the spleen viable counts were high (Table 1 ) may reflect the inadequacy of this late-developing protective response to deal effectively with very high bacillary loads, rather than implying no beneficial role for the T,u-cell population. These associations are admittedly correlative, and the formal demonstration of a regulatory role for T,u cells must await studies with purified or depleted cell populations.
Although this is the first published report of T,u cells in animals with tuberculosis, others have examined so-called T-non-y cells, a population presumably containing Tp cells as well as other T cells (7) . The precise antigen recognition capability of T,u cells remains to be determined. This initial significant elevation of the putative helper (T,u)-cell subset in BCG-vaccinated guinea pigs may contribute to the enhancement of the anti-tuberculous response and help prevent disease progression in these animals.
No effect of BCG vaccination on T-y-cell proportions was detected in either the spleens or peripheral blood of guinea pigs infected with M. tuberculosis. However, both vaccinated and nonvaccinated guinea pigs had elevated T-y-cell levels in the spleens and peripheral blood during the first week following aerogenic challenge. Disease duration was associated with a progressive decline in T-y-cell subsets in both organs. However, the rebound initiated at 4 weeks suggests an elevation in T-y percentages in the later stages of disease. These results would be in concordance with those of Kleinhenz and Ellner (8) , who demonstrated increased Tycell percentage in patients presenting with clinical tuberculosis and who were presumably much further into the disease process. Our study concentrated primarily on events that occur early in infection. The initial decline in T-y-cell percentages that we observed may be attributed to a temporary shedding of the Fc-y receptor or a departure of Ty cells to peripheral tissue sites.
Factors which may modify the proportions of T,u and T-y cells in tuberculous animals include their antigenic reactivity and their interaction with antigen-antibody complexes containing the homologous isotype. Tsuyuguchi (3, 7) . It has been suggested that T-y cells may play a dichotomous role in the regulation of the anti-tuberculous response (7) . Coculture studies conducted in patients with active tuberculosis demonstrated that purified Ty cells depressed PPD-induced blastogenesis of T-nony cells; however, they also demonstrated that T-y cells served to down-regulate monocyte-induced suppression (8) . In another study, Ty cells were cited as the target population for a soluble suppressor factor (26) . The functional heterogeneity of Ty cells may allow for the coordination of immunoregulatory events involved in maintaining the balance between antigen reactivity and suppression.
Using a highly relevant guinea pig model of pulmonary tuberculosis, we applied a functional assay for the presence of Fc receptors on T lymphocytes to study BCG vaccineinduced resistance to respiratory tuberculosis infection. There is sufficient clinical and experimental evidence to suggest a role for FcR+ cells in the regulation of immunity in patients with tuberculosis (8, 24) . BCG vaccination stimulated antigen-specific T-cell responses both in vivo and in vitro and has been shown to obviate disease progression. T-cell subsets defined by the presence of Fc receptors, particularly Tp. cells, could mediate this BCG-induced disease resistance. It may be that the Fc-receptor-bearing T cell serves as an intermediary between the humoral and cellmediated arms of the immune response, coordinating the balance between the heterogeneous cell populations involved in generating functional immunity. Future work to define the role of FcR+ T cells in the anti-tuberculous response will involve the study of purified TRx-and T-y-cell populations both in vivo and in vitro. Identification of the specific cell populations pertinent to the acquisition of successful anti-tuberculous immunity will aid in the development of new and more efficacious means for controlling, if not eradicating, tuberculosis throughout the world.
